بدائل البحث:
ng decrease » nn decrease (توسيع البحث), _ decrease (توسيع البحث), gy decreased (توسيع البحث)
we decrease » _ decrease (توسيع البحث), nn decrease (توسيع البحث), mean decrease (توسيع البحث)
a decrease » _ decrease (توسيع البحث), _ decreased (توسيع البحث), _ decreases (توسيع البحث)
b decrease » _ decrease (توسيع البحث), b1 decreased (توسيع البحث), ob decreased (توسيع البحث)
ng decrease » nn decrease (توسيع البحث), _ decrease (توسيع البحث), gy decreased (توسيع البحث)
we decrease » _ decrease (توسيع البحث), nn decrease (توسيع البحث), mean decrease (توسيع البحث)
a decrease » _ decrease (توسيع البحث), _ decreased (توسيع البحث), _ decreases (توسيع البحث)
b decrease » _ decrease (توسيع البحث), b1 decreased (توسيع البحث), ob decreased (توسيع البحث)
-
161
-
162
-
163
-
164
-
165
-
166
-
167
Phenotypic delay decreases the probability of a bacterial infection surviving antibiotic treatment.
منشور في 2020"…(d) For the dilution mechanism, the probability of survival decreases with the number of molecules <i>n</i> which need to be diluted out before the cell becomes phenotypically resistant. …"
-
168
Juvenile demyelination leads to a decrease in axonal complexity of PFC PV interneurons.
منشور في 2025"…<b>G</b>. <i>Left.</i> Total proximal axonal length is decreased in cuprizone-treated PFC PV interneurons compared with control cells (<i>t test; n = 10/9 cells per group, **p < 0.01</i>)<i>. …"
-
169
-
170
-
171
-
172
-
173
-
174
-
175
-
176
DART-ID decreases missing datapoints across runs.
منشور في 2019"…Only peptides seen in >50% of experiments are included. (<b>b</b>) Decrease in missing data across all runs after applying DART-ID, for SCoPE-MS and the two bulk sets from <a href="http://www.ploscompbiol.org/article/info:doi/10.1371/journal.pcbi.1007082#pcbi.1007082.g004" target="_blank">Fig 4</a> at 1% FDR. …"
-
177
-
178
-
179
-
180
Development of (2-(Benzyloxy)phenyl)methanamine Derivatives as Potent and Selective Inhibitors of CARM1 for the Treatment of Melanoma
منشور في 2024"…In our previous study, we have identified a series of type I PRMT inhibitors, among which ZL-28-6 (<b>6</b>) exhibited increased activity against CARM1 while displaying decreased potency against other type I PRMTs. …"